Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2026March › 19

Wegovy

3 months ago

The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.
Experts are saying they could be priced as low as $15 per month.

Researchers find snake metabolite that suppresses appetite of obese mice ‘without some of side-effects’ of GLP-1 drugs

Pythons follow the ultimate crash diet, swallowing an antelope in a single sittin…

The drugs - known as GLP-1 receptor agonists - were linked to a significantly lower risk of mental health deterioration in people already struggling with mental health conditions.

page 1 of 1